Expansion of Biomedical Bonding AB:s Board of Directors
With the growing need for novel treatments in the orthopedic and dental market, Biomedical Bonding AB (BMB) is continuing to pursue an expansion of its organization. BMB is now proud to announce that Lena Söderström and Catrin Molund has joined as members of the board.Biomedical Bonding AB aims to introduce a new paradigm in bone fracture and restoration surgery via our composite resin technology Bonevolent™. With customizable implant treatments focused on tissue-friendliness and safety, we want to improve the surgical outcome and enhance the patient life quality. Its simplicity provides